Login

Houlihan Lokey CEO Scott Beiser celebrates the firm's IPO at the NYSE, discussing M&A activity and key trends in restructuring. 00:10:00

Share On Facebook Share On Twitter

Scott Beiser is a Co-Chairman of Houlihan Lokey

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Transforming Lands, Building Futures: A Conversation on Agricultural Development | Alejandro Elsztain, CEO, CRESUD S.A.C.I.F. y A.
00:10:00
6 Mistakes to Avoid in Retirement and What to Do Instead | Jonathan Harrison, CEO, Sound Stewardship, LLC.
00:10:00
Marco Claudio Grillo Discusses Abitare In’s Milestones and Future Goals at AIM Investor Day | Marco Claudio Grillo, CEO , Abitare In SpA.
00:10:00
CEO Michiel Langezaal is excited about his EV-inspired moment. | MICHIEL LANGEZAAL, CEO AT FASTNED BV
00:10:00
Penguin Alma Palladium Project: Unveiling Potential in South Africa
00:10:00
Litigating Offshore: Strategic Benefits of U.S. Courts for Offshore Fund Claims | Jonathan Sablone - Partner, Nixon Peabody & Colette Wilkins - Partner, Walkers
00:10:00
Government Resources Advances Burkina Faso Gold Project with Upcoming Resource Estimate
00:10:00
Concerns Over Federal Reserve Credibility Amid Inflation Strategy | Scott Sperling, CO-CEO, Thomas H. Lee Partners .
00:10:00
Inside the Mind of T. Wilson Eglin: Exclusive Insights on Lexington Realty LXP
00:10:00
Exploring Market Trends and Economic Insights: A Global Overview
00:10:00
We support leading companies across all sectors of financial services, including lending, credit & banking|Ben Savage,General Partner, Clocktower Technology Ventures
00:10:00
Navigating Challenges and Driving Growth in Alternative Investments | Marc Rowan, CEO, Apollo Global Management.

© 2026 Nehu